NASDAQ: NRSNNeurosense Therapeutics Ltd Stock Ownership - Who owns Neurosense Therapeutics?
Insider buying vs selling
Have Neurosense Therapeutics Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when NRSN insiders and whales buy or sell their stock.
NRSN Shareholders
What type of owners hold Neurosense Therapeutics Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ferenc Tracik | 1.74% | 428,011 | $329.57k | Insider |
| Mark Leuchtenberger | 0.50% | 122,951 | $94.67k | Insider |
| Yorkville Advisors Global LP | 0.41% | 100,000 | $77.00k | Institution |
| Cary J. Claiborne | 0.41% | 99,898 | $76.92k | Insider |
| Christine A. Pellizzari | 0.41% | 99,898 | $76.92k | Insider |
| Roy Golan | 0.31% | 76,844 | $59.17k | Insider |
| Two Sigma Investments LP | 0.21% | 51,545 | $39.69k | Institution |
| Meitav Investment House Ltd 1 | 0.16% | 40,000 | $30.80k | Institution |
| Gts Securities LLC | 0.15% | 35,753 | $27.53k | Institution |
| Ubs Group Ag | 0.13% | 30,871 | $23.77k | Institution |
NRSN vs Biotech Stocks
Neurosense Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.